Detection of a Single Microdose of Testosterone and Recombinant EPO in Healthy Volunteers
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Carmel Heiland und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Testosterone, Erythropoietin, Substance Abuse Detection. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Doping with testosterone (T) and erythropoietin (EPO) in low doses (micro‐doping) is a challenge to detect. Here, we have investigated the ability to detect micro‐doping of recombinant human (rhEPO) and testosterone (T) after administration of a single dose of subcutaneous Eporatio (15 IU/kg) and transdermal Testogel (100 mg) to healthy males. For rhEPO detection in urine, MAIIA EPO purification kits 3F6 (#1410) and 7D3 (#1460) were used for ITP and CP analyses, respectively, whereas kit 3F6 (#1430) was used for dried blood spots (Tasso). The sensitivity to detect rhEPO in Tasso was investigated and compared with previous detection results for Capitainer and Mitra. For T detection, the urinary and capillary serum steroid profile and IRMS analysis were performed. It was possible to detect administration of 15 IU/kg Eporatio with high sensitivity with our ITP method up to 72 h after administration, and the CP findings supported the ITP findings. Tasso provides less sensitivity in detecting Eporatio than Mitra and Capitainer. With IRMS, 100% of the samples analyzed were positive, also when not associated with elevated urinary T/E or 5αAdiol/E ratios. As an alternative, high systemic T levels aligned with positive IRMS results, highlighting the value of serum T as a complementary biomarker. Overall, the World Anti‐Doping Agency ITP and CP methods employed today show good sensitivity towards detection of micro‐dosing of rhEPO and T.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
- Stockholm Doping Control Laboratory, Medical Unit Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.
- Sankt Görans Sjukhus, Stockholm, Sweden.
- Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Lena Ekström
Zitieren
APA
Heiland, C., Hopcraft, O., Johanson, M., Pohanka, A., Lehtihet, M., & Ekström, L. (2025). Detection of a Single Microdose of Testosterone and Recombinant EPO in Healthy Volunteers. Drug Testing and Analysis. https://doi.org/10.1002/dta.3932
Vancouver
Heiland C, Hopcraft O, Johanson M, Pohanka A, Lehtihet M, Ekström L. Detection of a Single Microdose of Testosterone and Recombinant EPO in Healthy Volunteers. Drug Testing and Analysis. 2025. doi:10.1002/dta.3932
BibTeX
@article{Heiland2025,
author = {Heiland, Carmel and Hopcraft, Oscar and Johanson, Mats and Pohanka, Anton and Lehtihet, Mikael and Ekström, Lena},
title = {Detection of a Single Microdose of Testosterone and Recombinant EPO in Healthy Volunteers},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3932}
}
EUVIMED